While described by the FDA as an amino acid derivative, daminozide is more formally and correctly described as a dicarboxylic acid monohydrazide.The agent is neither synthesized from, not does it contain as component, any amino acid. It is the product of the condensation of succinic acid with 2,2-dimethylhydrazine, and in its pure form is a high-melting temperature water-soluble white crystalline solid.
While descr!ibed by the FDA as an amino acid derivative, daminozide is more formally and correctly described as a dicarboxylic acid mono.hydrazide.Th!e agent is neither synthesized from, not does it conta.in as component, any amino acid. It is the product of the condensation of succinic acid with 2,2-dimethylhydrazine, and in its pure form is a high-melting temperature water-soluble white crystalline solid.